Concepedia

The use of a HEMOCHRON® JR. HEMONOX™ point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures

Soumaya El Rouby, Marc Cohen, Andréa Cristina Silva Gonzales, Debra Hoppensteadt, Ted Lee, Márcia L. Zucker, Khaula Khalid, Frank M. LaDuca, Jawed Fareed

Journal of Thrombosis and Thrombolysis · 2006 · 15 citations · 30 references

DOI

Concepts

References

30

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

Marc J. Cohen, Christine Demers, Enrique Gurfinkel et al. · New England Journal of Medicine · 1997 · 1.4K citations · Full text

, , +14

Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

Elliott M. Antman, Carolyn H. McCabe, Enrique Gurfinkel et al. · Circulation · 1999 · 1.1K citations · Full text

, , +15

Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy

JAMA · 2004 · 788 citations · Full text

, , +17

Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris

J.‐P. Collet, Gilles Montalescot, Linda Lison et al. · Circulation · 2001 · 219 citations · Full text

, , +16

Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide

Shaun G. Goodman, David Fitchett, Paul W. Armstrong et al. · Circulation · 2003 · 200 citations

, , +16